A rapid HPLC assay for voriconazole in human plasma
- 1 September 1998
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 17 (8), 1449-1453
- https://doi.org/10.1016/s0731-7085(98)00004-1
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Determination of a new antifungal agent, voriconazole, by multidimensional high-performance liquid chromatography with direct plasma injection onto a size-exclusion columnJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- Comparison of voriconazole (UK-109,496) and itraconazole in prevention and treatment of Aspergillus fumigatus endocarditis in guinea pigsAntimicrobial Agents and Chemotherapy, 1997
- Validation of liquid chromatographic and gas chromatographic methods Applications to pharmacokineticsJournal of Chromatography B: Biomedical Sciences and Applications, 1996
- Novel antifungal 2-aryl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivatives with high activity against Aspergillus fumigatusBioorganic & Medicinal Chemistry Letters, 1996
- Rapid high performance liquid chromatographic assay for antifungal agents in human seraJournal of Antimicrobial Chemotherapy, 1996
- Application issues in bioanalytical method validation, sample analysis and data reportingJournal of Pharmaceutical and Biomedical Analysis, 1995
- Analytical Methods Validation: Bioavailability, Bioequivalence, and Pharmacokinetic StudiesJournal of Pharmaceutical Sciences, 1992
- Evaluation of the relative efficacy of various techniques for deproteinizing plasma samples prior to high-performance liquid chromatographic analysisJournal of Chromatography B: Biomedical Sciences and Applications, 1981